Provention Bio (PRVB) Financials

$24.98

$0.00 (0.00%)

As on 27-Apr-2023 09:30EDT

Market cap

$2,375 Mln

Revenue (TTM)

$13 Mln

P/E Ratio

--

P/B Ratio

5.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	12.90	1.40	--	--	--	--
Cost of Revenue	0.51	--	--	--	--	--
Gross Profit	12.38	1.40	--	--	--	--
Operating Expenses	140.54	116.97	99.69	44.37	26.81	9.14
Operating Profit (EBIT)	-128.16	-115.58	-99.69	-44.37	-26.81	-9.14
Other Income	--	0.15	0.58	1.09	0.15	--
Profit before Tax	-126.96	-115.43	-99.10	-43.29	-26.67	-9.13
Provision for Tax	-13.39	-1.00	-0.52	-1.09	-0.19	--
Profit after Tax (Net Income)	-113.57	-114.43	-98.58	-42.20	-26.48	-9.13
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	-114.43	-98.58	-43.29	-26.75	-9.48

Liabilities ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	121.85	-292.07	-177.64	-79.06	59.66	20.15
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	24.62	2.10	0.72	1.78	0.57	1.00
Current Liabilities	90.39	22.79	16.73	3.84	1.87	1.28
Total Liabilities	236.86	135.62	128.52	86.00	61.53	22.43

Assets ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	62.21	34.53	1.97	--	--	--
Current Assets	174.65	101.10	126.55	86.00	61.53	22.43
Total Assets	236.86	-267.19	128.52	86.00	61.53	22.43
Total Debt*	23.91	0.59	0.72	--	--	--
Net Current Assets	84.26	78.31	109.82	82.16	59.66	21.15

Cashflow ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	-75.41	-95.39	-76.34	-36.07	-22.64	-4.88
Cash Flow from Investing Activities	--	-31.10	25.17	-46.25	-46.25	-46.25
Cash from Financing Activities	129.38	102.38	114.29	62.94	59.35	26.72
Net Cash Inflow / Outflow	--	-24.10	63.13	-19.37	36.71	--

Financials Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-1.51	-1.82	-1.90	-1.03	-1.20	-1.01
Cash EPS ($)	-1.50	-1.81	-1.90	-1.03	-1.20	-1.01
Adjusted Book Value ($)	1.62	--	--	--	2.71	2.24
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-1.01	-1.51	-1.47	-0.88	-1.03	-0.54
Free Cash Flow per Share ($)	-1.02	-1.53	-1.49	-0.88	-1.03	-0.54

Profitability Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	155.86	48.86	77.02	434.96	-66.35	-91.39
ROE (%)	133.43	48.72	76.81	434.96	-66.35	-91.39
ROA (%)	-60.98	-86.64	-91.91	-57.21	-63.07	-80.99
EBIT Margin (%)	-993.88	-8,285.16	--	--	--	--
Net Margin (%)	-880.69	-7,425.83	-16,909.26	-3,882.06	-17,770.47	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	8.24	--	--	--	--	--
EBIT Growth (%)	-10.89	-15.94	-124.66	-66.41	-191.95	-1,283.83
Net Profit Growth (%)	0.76	-16.08	-133.62	-59.37	-189.91	-5,445.06
EPS Growth (%)	0.17	0.04	-0.84	0.14	-0.19	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	-6.98	-3.09	-8.94	-14.48	-1.47	--
Price / Book Value	6.51	-1.21	-4.96	-7.73	0.65	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-5.23	-2.26	-7.62	--	0.74	--
Close Price ($)	10.57	5.62	16.94	14.90	1.77	--
High Price ($)	10.63	20.05	19.19	22.82	8.00	--
Low Price ($)	3.19	5.51	4.72	1.52	1.53	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	0.20	0.00	0.00	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	1.93	4.44	7.56	22.39	32.89	17.54
Quick Ratio	1.92	--	--	--	--	--
Interest Coverage	-123.59	-791.63	-161.83	--	--	--

Operating Efficiency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	10.54	--	--	--	--	--
Asset Turnover	0.07	0.01	--	--	--	--
Receivable days	38.49	--	--	--	--	--
Inventory Days	878.17	--	--	--	--	--
Payable days	3,676.40	--	--	--	--	--
Cash Conversion Cycle	-2,759.74	--	--	--	--	--